[HTML][HTML] Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement
…, P Kuna, C Ljørring, JL Prieto, HH Villesen - Respiratory …, 2015 - Elsevier
Background Exacerbations are a key outcome in clinical research, providing patient-relevant
information about symptomatic control, health state and disease progression. Generally …
information about symptomatic control, health state and disease progression. Generally …
Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial
Importance The house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet is
a potential novel treatment option for HDM allergy–related asthma. Objectives To evaluate …
a potential novel treatment option for HDM allergy–related asthma. Objectives To evaluate …
Cerebral kinetics of oxycodone in conscious sheep
HH Villesen, DJR Foster, RN Upton… - Journal of …, 2006 - Elsevier
Oxycodone is an opioid analgesic that is administered orally or parenterally. The time-course
of opioid action is a function of the systemic kinetics of the opioid, and the rate and extent of …
of opioid action is a function of the systemic kinetics of the opioid, and the rate and extent of …
Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients
HH Villesen, AM Banning, RH Petersen… - … and clinical risk …, 2007 - Taylor & Francis
Background An increased and prolonged duration of pain relief after morphine administration
has been found in elderly patients. Whether this is due to alterations in pharmacokinetics, …
has been found in elderly patients. Whether this is due to alterations in pharmacokinetics, …
Symptoms and side effects in chronic non‐cancer pain: patient report vs. systematic assessment
…, LL Christrup, J Højsted, HH Villesen… - Acta …, 2011 - Wiley Online Library
Background: Relieving distressing symptoms and managing the side effects of analgesics
are essential in order to improve quality of life and functional capacity in chronic non‐cancer …
are essential in order to improve quality of life and functional capacity in chronic non‐cancer …
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers
…, NH Jensen, BN Nielsen, U Skram, HH Villesen… - European journal of …, 2007 - Springer
Objective The aim of this investigation was to characterize the pharmacokinetics of
buprenorphine following administration of an intravenous (iv) infusion. To date, the population …
buprenorphine following administration of an intravenous (iv) infusion. To date, the population …
Tolerability of the SQ tree SLIT tablet in adults
AO Birk, JS Andersen, HH Villesen, MA Steffensen… - Clinical Therapeutics, 2017 - Elsevier
… AO Birk, JS Andersen, HH Villesen, and MA Steffensen are employed by ALK. MA Calderon
has received consultancy and lecture fees from ALK, Stallergenes, Merck, Allergopharma, …
has received consultancy and lecture fees from ALK, Stallergenes, Merck, Allergopharma, …
Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers
HH Villesen, K Kristensen, SH Hansen… - European journal of …, 2007 - Springer
… Villesen … In the present study, the plasma concentration peaks after 50 mg occurred
slightly later than previously published by Villesen et al. (t 1 : 3.5 vs. 2.5; t 2 : 21.3 vs. …
slightly later than previously published by Villesen et al. (t 1 : 3.5 vs. 2.5; t 2 : 21.3 vs. …
Pharmacokinetics of M6G following intravenous and oral administration in healthy volunteers
HH Villesen, B Hedal, J Engbaek, S Frokjaer… - Acute Pain, 2006 - Elsevier
BACKGROUND: The active metabolite of morphine, morphine-6-glucuronide (M6G), shows
an analgesic effect that is equivalent to morphine. The bioavailability is low (11–13%) when …
an analgesic effect that is equivalent to morphine. The bioavailability is low (11–13%) when …
Blood–brain distribution of morphine‐6‐glucuronide in sheep
HH Villesen, DJR Foster, RN Upton… - British journal of …, 2006 - Wiley Online Library
Background and purpose: At present there are few data regarding the rate and extent of
brain–blood partitioning of the opioid active metabolite of morphine, morphine‐6‐glucuronide (…
brain–blood partitioning of the opioid active metabolite of morphine, morphine‐6‐glucuronide (…